143 related articles for article (PubMed ID: 5080017)
1. Renal clearance and brain tumor localization in mice of 99 m Tc compounds of (Sn), DTPA, (iron-ascorbic acid) DTPA, and iron-ascorbic acid.
Konikowski T; Glenn HJ; Haynie TP
J Nucl Med; 1972 Nov; 13(11):834-42. PubMed ID: 5080017
[No Abstract] [Full Text] [Related]
2. Brain tumor-scanning agents compared in an animal model.
Konikowski T; JPAHNS MF; Haynie P; Glenn HJ
J Nucl Med; 1975 Mar; 16(3):200-7. PubMed ID: 46273
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m stannous citrate brain-tumor uptake in mice: concise communication.
Haynie TP; Konikowski T; Glenn HJ
J Nucl Med; 1977 Sep; 18(9):915-8. PubMed ID: 893790
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of 99m Tc-, 113m In-, and 169 Yb-DTPA compounds in brain sarcoma and kidneys of mice.
Haynie TP; Konikowski T; Glenn HJ
J Nucl Med; 1972 Mar; 13(3):205-10. PubMed ID: 5058238
[No Abstract] [Full Text] [Related]
5. Kinetics of 67 Ga compounds in brain sarcomas and kidneys of mice.
Konikowski T; Glenn HJ; Haynie TP
J Nucl Med; 1973 Mar; 14(3):164-71. PubMed ID: 4685412
[No Abstract] [Full Text] [Related]
6. [Complexes 99mTc-Sn-DTPA, 99mTc-Fe-ascorbic acid, and 99mTc-Sn-calcium-gluconogalactogluconate in the diagnosis of renal function and morphology (author's transl)].
Licińska I; Graban W; Jakubowski W; Krasucki T; Lachnik E; Wiza J; Zulczyk W; Smoliński S; Zielińska B
Pol Przegl Radiol Med Nukl; 1977; 41(1):57-61. PubMed ID: 859758
[No Abstract] [Full Text] [Related]
7. The effect of perchlorate on the localization of 99mTc-pertechnetate in a mouse brain sarcoma.
Konikowski T; Haynie TP
J Nucl Med; 1970 Jul; 11(7):443-8. PubMed ID: 4317181
[No Abstract] [Full Text] [Related]
8. Renal uptake of 99m Tc-iron-ascorbic acid complex in man.
Hauser W; Atkins HL; Richards P
Radiology; 1971 Dec; 101(3):637-41. PubMed ID: 5129108
[No Abstract] [Full Text] [Related]
9. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
Uehara H; Miyagawa T; Tjuvajev J; Joshi R; Beattie B; Oku T; Finn R; Blasberg R
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1239-53. PubMed ID: 9390656
[TBL] [Abstract][Full Text] [Related]
10. Technetium-iron-ascorbic acid complex. A good brain scanning agent.
Stapleton JE; Odell RW; McKamey MR
Am J Roentgenol Radium Ther Nucl Med; 1967 Sep; 101(1):152-6. PubMed ID: 4292155
[No Abstract] [Full Text] [Related]
11. The chemical state of 99m Tc in biomedical products. II. The chelation of reduced technetium with DTPA.
Eckelman WC; Meinken G; Richards P
J Nucl Med; 1972 Aug; 13(8):577-81. PubMed ID: 5041632
[No Abstract] [Full Text] [Related]
12. Shortcomings of 99m Tc-pertechnetate as a tracer for brain tumor detection as shown by well counting of human brain tumors and a mouse ependymoblastoma.
Schwartz ML; Tator CH
J Nucl Med; 1972 May; 13(5):321-7. PubMed ID: 4336247
[No Abstract] [Full Text] [Related]
13. [Studies on the accumulation of 99m technetium-iron(II)-ascorbic acid complex in rat myelosarcoma T58].
Hill M; Habighorst LV; Brod KH
Strahlentherapie; 1973 Mar; 145(3):346-52. PubMed ID: 4698020
[No Abstract] [Full Text] [Related]
14. [Renal and cerebral scintigraphy with the aid of a technetium 99 M-iron-ascorbic acid complex].
Robillard J; Goussard J; Couette JE; Bloquel J; Cheguillaume J
J Radiol Electrol Med Nucl; 1969 May; 50():Suppl 5:385-8. PubMed ID: 5401408
[No Abstract] [Full Text] [Related]
15. 99m Tc-DTPA preparations.
Eckelman WC; Richards P; Hauser W; Atkins HL
J Nucl Med; 1971 Oct; 12(10):699. PubMed ID: 5112222
[No Abstract] [Full Text] [Related]
16. Use of Fe(II) or Sn(II) alone for technetium labeling of albumin.
Lin MS; Winchell HS; Shipley BA
J Nucl Med; 1971 May; 12(5):204-11. PubMed ID: 5580834
[No Abstract] [Full Text] [Related]
17. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
[TBL] [Abstract][Full Text] [Related]
18. A critical evaluation of 99mTc-Fe-ascorbic acid complex as a renal scanning agent.
Winston MA; Halpern SE; Weiss ER; Endow JS; Blahd WH
J Nucl Med; 1971 Apr; 12(4):171-5. PubMed ID: 5550096
[No Abstract] [Full Text] [Related]
19. Recently developed radiopharmaceuticals: ytteribium-169 DTPA and technetium-99m microspheres.
Wagner HN; Hosain F; Rhodes BA
Radiol Clin North Am; 1969 Aug; 7(2):233-41. PubMed ID: 5808177
[No Abstract] [Full Text] [Related]
20. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
Tofe AJ; Francis MD
J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
